GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Current Accrued Expense

Adbiotech Co (XKRX:179530) Current Accrued Expense : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Current Accrued Expense?

Adbiotech Co's Current Accrued Expense for the quarter that ended in Mar. 2024 was ₩0 Mil.


Adbiotech Co Current Accrued Expense Historical Data

The historical data trend for Adbiotech Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Current Accrued Expense Chart

Adbiotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
- - - - -

Adbiotech Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Adbiotech Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Adbiotech Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Adbiotech Co (XKRX:179530) Business Description

Traded in Other Exchanges
N/A
Address
39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398
Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines